title: Gene marking and gene therapy for transplantation medicine.
abstract: The classic application for gene therapy is in the correction of single gene defects, although this has been complicated by the low efficiency of gene transfer into hematopoietic cells. Gene therapy, however, has potential for the modulation of tumor cell growth, drug sensitivity, and antitumor immune responses. In addition, gene marking can be used, in spite of this limited transfer efficiency, to provide information on hematopoiesis, sources of cancer relapse after stem cell transplant, and the relative efficacy of graft manipulation techniques. This article reviews the applications of gene therapy and gene marking in transplantation medicine.
authors.affiliation: Division of Bone Marrow Transplantation, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.
authors.forename: D
authors.initials: D
authors.lastname: Dilloo
authors.forename: D R
authors.initials: DR
authors.lastname: Rill
authors.forename: M E
authors.initials: ME
authors.lastname: Grossmann
authors.forename: T
authors.initials: T
authors.lastname: Leimig
authors.forename: M K
authors.initials: MK
authors.lastname: Brenner
mesh_terms: D015415:Biomarkers; D018014:Gene Transfer Techniques; D015316:Genetic Therapy; D018380:Hematopoietic Stem Cell Transplantation / Q000379:methods*; D006801:Humans
chemical_list: D015415:Biomarkers